Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial

BACKGROUND: GHB (gamma-hydroxybutyrate) and its pro-drugs GBL (gamma-butyrolactone) and 1,4-butanediol (1,4-BD) are central nervous system depressants whose street names include ‘G’ and ‘liquid ecstasy’. They are used recreationally predominately for their stimulant and pro-sexual effects or for sed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingford-Hughes, Anne, Patel, Yash, Bowden-Jones, Owen, Crawford, Mike J., Dargan, Paul I., Gordon, Fabiana, Parrott, Steve, Weaver, Tim, Wood, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039898/
https://www.ncbi.nlm.nih.gov/pubmed/27677382
http://dx.doi.org/10.1186/s13063-016-1593-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039898/
https://www.ncbi.nlm.nih.gov/pubmed/27677382
http://dx.doi.org/10.1186/s13063-016-1593-9

Ejemplares similares